Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma

Author： Kriegmair M.   Oberneder R.   Hofstetter A.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.45, Iss.5, 1995-05, pp. : 758-762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of renal cell carcinoma with 5-fluorouracil and alfa-interferon

By Gebrosky N.P.   Koukol S.   Nseyo U.O.   Carpenter C.   Lamm D.L.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 863-868

Elsevier

Access to resources Recommend Favorite

Prognostic indicators for response to therapy and survival in patients with metastatic renal cell cancer treated with interferon alpha-2 beta and vinblastine

By Papadopoulos I.   Rudolph P.   Weichert-Jacobsen K.   Thiemann O.   Papadopoulou D.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 373-378

Elsevier

Access to resources Recommend Favorite

Treatment of metastatic renal cell carcinoma and renal pelvic cancer

By Tanji Nozomu  

Clinical and Experimental Nephrology, Vol. 15, Iss. 3, 2011-06 ,pp. : 331-338

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic Resection for Metastatic Renal Cell Carcinoma to the Pancreas

By Karimi Kamran M.H.   McFadden David W.  

The American Surgeon, Vol. 73, Iss. 11, 2007-11 ,pp. : 1158-1160

Southeastern Surgical Congress

Access to resources Recommend Favorite

Cytotoxic chemotherapy for metastatic renal cell carcinoma

By Stadler Walter  

Der Urologe A, Vol. 43, Iss. 3, 2004-09 ,pp. : 145-146

Springer Publishing Company

Access to resources Recommend Favorite